Cell-free and Concentrated Ascites Reinfusion Therapy for Refractory Ascites in Cirrhosis in Post-marketing Surveillance and the Role of Tolvaptan

OBJECTIVE: Ascites becomes refractory to diuretics in cirrhotic patients, who then require repeated large-volume paracentesis or cell-free and concentrated ascites reinfusion therapy (CART). The objective of this study was to confirm the safety and efficacy of CART, evaluate the actual situations wi...

Descripción completa

Detalles Bibliográficos
Autores principales: Iwasa, Motoh, Ishihara, Tomoaki, Kato, Michio, Isoai, Ayako, Kobayashi, Ryosuke, Torii, Naoko, Soneda, Noriko, Takei, Yoshiyuki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Japanese Society of Internal Medicine 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6875447/
https://www.ncbi.nlm.nih.gov/pubmed/31292400
http://dx.doi.org/10.2169/internalmedicine.3091-19

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6875447/
https://www.ncbi.nlm.nih.gov/pubmed/31292400
http://dx.doi.org/10.2169/internalmedicine.3091-19

Ejemplares similares